Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-166,482
Closed -$7.62M 1243
2021
Q1
$7.62M Sell
166,482
-172,328
-51% -$7.22M 0.06% 361
2020
Q4
$11M Buy
338,810
+185,462
+121% +$5.37M 0.08% 294
2020
Q3
$3.25M Sell
153,348
-200,826
-57% -$4.18M 0.02% 577
2020
Q2
$7.27M Buy
354,174
+214,628
+154% +$4.15M 0.06% 349
2020
Q1
$2.45M Buy
139,546
+129,426
+1,279% +$3.99M 0.02% 582
2019
Q4
$397K Sell
10,120
-3,527
-26% -$130K ﹤0.01% 1189
2019
Q3
$488K Sell
13,647
-30,204
-69% -$1.08M ﹤0.01% 1266
2019
Q2
$1.53M Buy
+43,851
New +$1.52M 0.01% 999

Other funds holding SNV

Mackay Shields LLC's SNV Position: Q2 2021 in Review

Mackay Shields LLC sold out of Synovus (SNV) in Q2 2021, closing a stake of 166,482 shares — an estimated $7.62M sold.

Mackay Shields LLC first reported a position in SNV in Q2 2019 and held it in 8 quarters. The position peaked at $11M in Q4 2020. 378 funds tracked by Wall St. Rank hold SNV as of Q2 2021.

  • Mackay Shields LLC reported no remaining Synovus position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 166,482 Synovus shares in Q2 2021, an estimated $7.62M.
  • Mackay Shields LLC first reported a position in Synovus in Q2 2019 and held it in 8 quarters.
  • Mackay Shields LLC's Synovus position peaked at $11M in Q4 2020.
  • 378 funds tracked by Wall St. Rank held Synovus as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.